Democratizing NGS Analysis Without Compromising Performance
October 26, 2026
Alison Waterfield
Next-generation sequencing (NGS) can generate powerful insights for cell line development, but data alone is not enough. Scientists also need a practical way to analyze it, interpret the results, and turn those results into decisions. That is where a challenge emerges. Sophisticated NGS analysis can require command-line tools, coding, scripting, and specialized bioinformatics expertise. For process development scientists without that background, the specialist expertise required to run complex analyses independently can become a barrier to putting NGS data to work.
So how can organizations make sophisticated NGS analysis accessible to more scientists while maintaining the analytical performance they depend on?
That question is at the heart of the webinar Democratizing NGS Analysis for Cell Line Development. Chaojie Wang, Senior Scientist at Bristol Myers Squibb (BMS), takes viewers inside his team's experience working with Genedata to transfer and optimize an NGS sequence variant analysis workflow using Genedata Selector Playbooks.

Bringing NGS Analysis Closer to the Scientist
NGS provides the sensitivity and throughput needed to support sequence variant analysis in cell line development. Realizing its value depends on efficiently moving from raw data through preprocessing, analysis, reporting, and visualization. Automation and standardized workflows offer an opportunity to bring more of that process directly to scientists without requiring them to script or code every analysis themselves.
That is what democratization means in practice: not reducing the sophistication of the science, but enabling more scientists to put it to work while allowing bioinformatics experts to focus their expertise on more complex challenges.
Automating Without Compromising Performance
Making a complex scientific workflow easier to use must go hand in hand with maintaining the required analytical performance. Moving from expert-driven analysis toward more accessible, automated workflows therefore requires more than simply providing a user-friendly interface. Scientific workflows need to account for the parameters and decisions that shape results across different stages of analysis.
This raises the critical question: Can a more accessible, automated workflow deliver performance comparable to an established expert-driven approach?
Answering that question requires rigorous testing and optimization. Without confidence in the analysis, greater accessibility offers little scientific value.
Less Hands-on Routine Analysis, More Time for Science
Democratizing NGS analysis can change how scientific expertise is used. Greater automation and standardization can reduce the need for scientists to manually execute routine analytical steps. For process development teams, that can mean less dependence on specialist support for established analyses. For bioinformatics experts, it creates the opportunity to concentrate specialist knowledge where it adds greater value, including tackling more complex studies, improving workflows, and developing new analytical approaches.
The goal is not to remove bioinformatics expertise from NGS analysis. It is to use that expertise where it matters most.
And that distinction becomes increasingly important as organizations look beyond individual workflows toward more connected and scalable approaches to generating, managing, analyzing, and interpreting omics data.
What Comes Next for Cell Line Development?
The bigger opportunity extends beyond making individual NGS analyses easier to run. Advances in multi-omics, AI/ML, modeling, and automation are opening new possibilities for how scientists investigate and understand cell lines. Bringing together richer biological data with increasingly scalable analytical approaches could ultimately support a deeper mechanistic understanding of cell lines and more directed approaches to cell line engineering.
But realizing that potential starts with a much more immediate challenge: How do you put sophisticated analysis into the hands of more scientists without sacrificing performance?
Watch the webinar to discover the challenges BMS encountered along the way, how the optimized workflow ultimately compared with the legacy approach, and what greater automation meant in practice.